Walgreens Boots Alliance (WBA) closed at $18.35 in the latest trading session, marking a +1.27% move from the prior day.

Key Takeaways Walgreens Boots Alliance has reportedly begun efforts to solicit potential buyers for its U.K.-based Boots ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on Walgreens Boots Alliance (WBA – Research Report), with ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Walgreens Boots Alliance. If we consider the ...

Michael Cherny, an analyst from Leerink Partners, maintained the Hold rating on Walgreens Boots Alliance (WBA – Research Report). The associated price target remains the same with $22.00. Michael ...

Walgreens Boots Alliance (WBA) will launch its own brand of over-the-counter opioid overdose therapy, naloxone, at a lower ...

Nuvei, Walgreens Boots Alliance, and Johnson & Johnson will all trade ex-dividend for their respective upcoming dividends.

U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose ...

Leerink Partners raised the price target for the Walgreens Boots Alliance Inc (NASDAQ:WBA) stock to “a Market perform”. The rating was released on February 26, 2024, according to finviz. The research ...

Walgreens is working with advisors to hold preliminary talks with potential buyers. Boots is valued at close to $9 billion.